Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma
Status:
Unknown status
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Purpose To evaluate efficacy and safety of combigan(Brimonidine/Timolol) and 0.5% Timoptic
(Timolol) ophthalmic solutions in normal tension glaucoma patients.